Verition Fund Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-41,290
| Closed | -$227K | – | 3124 |
|
|
2025
Q1 | $227K | Sell |
41,290
-43,920
| -52% | -$241K | ﹤0.01% | 2347 |
|
|
2024
Q4 | $289K | Buy |
85,210
+8,700
| +11% | +$29.5K | ﹤0.01% | 2157 |
|
|
2024
Q3 | $218K | Buy |
76,510
+2,276
| +3% | +$6.49K | ﹤0.01% | 2141 |
|
|
2024
Q2 | $167K | Buy |
+74,234
| New | +$167K | ﹤0.01% | 2004 |
|
|
2023
Q4 | – | Sell |
-24,700
| Closed | -$45.9K | – | 2252 |
|
|
2023
Q3 | $45.9K | Sell |
24,700
-12,308
| -33% | -$22.9K | ﹤0.01% | 1835 |
|
|
2023
Q2 | $97K | Buy |
+37,008
| New | +$97K | ﹤0.01% | 1700 |
|
|
2022
Q4 | – | Sell |
-12,666
| Closed | -$20K | – | 2233 |
|
|
2022
Q3 | $20K | Hold |
12,666
| – | – | ﹤0.01% | 2175 |
|
|
2022
Q2 | $20K | Buy |
+12,666
| New | +$20K | ﹤0.01% | 2128 |
|